hotspot -WSS

hotspot

author：focus 2025-10-03 00:07:28 - browse：58559

Richard Neal. -- health policy coverage from STAT — Rep. Richard Neal (D-Mass.) Drew Angerer/Getty Images

WASHINGTON — A rift between Democrats and Republicans over health care transparency was on full display in the House on Wednesday.

Republicans on the House Ways & Means Committee introduced a package this week that they say would increase health care transparency, but Democrats and outside groups are arguing that it doesn’t go far enough to force companies to disclose information about their ownership. They also think it goes too easy on the private equity firms that are buying up health care practices.

“There was an opportunity here for bipartisanship, but I think we ought to reference that in the past tense,” said ranking Democrat Richard Neal (D-Mass.).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Addressing health care workers' trauma can help fight burnout

entertainment

leisure time

WSS

Obesity drugs seen as possible treatment for liver disease MASH

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

He's a Nobel laureate. Critics say he was misleading on Covid

Alabama frozen embryo ruling has major implications for IVF clinics

PBM reform efforts get punted in Congress

Scrutiny of post

hotspot

hotspot

explore

New air purifier tech could be key to improving indoor air quality

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

BioMarin wins approval for gene therapy to treat hemophilia A

For longer

Anesthesiologist group: stop taking Ozempic before surgery

Alabama hospital puts IVF treatments on hold

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Community Health Systems hospitals under DOJ investigation

How one medical school became remarkably diverse

UnitedHealth argues against case alleging wrongful AI care denials

explore

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

At flashy new research hub, AstraZeneca lays out ambitious growth goals

ASCO eve: Let’s set the table for this year's meeting

Liver decline slowed by off

Cue Health, Covid

Making the case for fair compensation in clinical trials

entertainment

leisure time

knowledge

explore